Together with previous reports, these data suggest that the antihypertensive drug losartan, an AT1 receptor blocker that blunts TGF-β activation, may be an effective drug in the early secondary prevention of aortic media degeneration and aneurysm formation. The gene discussed is AGTR1; the disease is aneurysm.